Two-dimensional nanomaterials in cancer theranostics

Jiuhai Wang; Mo Yang

doi:10.1016/B978-0-12-815341-3.00011-0

Two-dimensional nanomaterials in cancer theranostics

Jiuhai Wang, Mo Yang

Research output: Chapter in book / Conference proceeding › Chapter in an edited book (as author) › Academic research › peer-review

11 Citations (Scopus)

Abstract

In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C₃N₄), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS₂, MnO₂, and WS₂), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

Original language	English
Title of host publication	Theranostic Bionanomaterials
Publisher	Elsevier
Pages	263-288
Number of pages	26
ISBN (Electronic)	9780128153413
ISBN (Print)	9780128153420
DOIs	https://doi.org/10.1016/B978-0-12-815341-3.00011-0
Publication status	Published - 1 Jan 2019

Keywords

2d nanomaterials
Drug release
Theranostics
Tumor therapy

ASJC Scopus subject areas

Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

More information

10.1016/B978-0-12-815341-3.00011-0

Cite this

@inbook{4afe52f270a24396a2d2b568eb5eb897,

title = "Two-dimensional nanomaterials in cancer theranostics",

abstract = "In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.",

keywords = "2d nanomaterials, Drug release, Theranostics, Tumor therapy",

author = "Jiuhai Wang and Mo Yang",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-815341-3.00011-0",

language = "English",

isbn = "9780128153420",

pages = "263--288",

booktitle = "Theranostic Bionanomaterials",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Two-dimensional nanomaterials in cancer theranostics

AU - Wang, Jiuhai

AU - Yang, Mo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

AB - In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

KW - 2d nanomaterials

KW - Drug release

KW - Theranostics

KW - Tumor therapy

UR - http://www.scopus.com/inward/record.url?scp=85082621655&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-815341-3.00011-0

DO - 10.1016/B978-0-12-815341-3.00011-0

M3 - Chapter in an edited book (as author)

AN - SCOPUS:85082621655

SN - 9780128153420

SP - 263

EP - 288

BT - Theranostic Bionanomaterials

PB - Elsevier

ER -

Two-dimensional nanomaterials in cancer theranostics

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

More information

Other files and links

Fingerprint

Cite this